As the Chief Executive Officer of PDC Pharma Strategy, Penelope Przekop brings over three decades of extensive experience in the pharmaceutical industry, underscoring her expertise in regulatory affairs, clinical development, and quality assurance. Her journey began in the late 1980s, where she laid a solid...
As the Chief Executive Officer of PDC Pharma Strategy, Penelope Przekop brings over three decades of extensive experience in the pharmaceutical industry, underscoring her expertise in regulatory affairs, clinical development, and quality assurance. Her journey began in the late 1980s, where she laid a solid foundation in preclinical research at Hoechst-Rousell, eventually transitioning into regulatory affairs. This pivotal move allowed her to hone her skills in Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), which are critical in ensuring compliance and quality in drug development.
At PDC Pharma Strategy, Penelope is at the forefront of driving innovative, risk-based strategies that empower clients to navigate the complexities of global pharmaceutical regulations. Her leadership is instrumental in developing comprehensive corporate compliance frameworks and GxP quality systems that not only meet but exceed industry standards. Key projects under her guidance include enhancing pharmacovigilance protocols and optimizing clinical operations, ensuring that clients can deliver safe and effective therapeutics to market efficiently.
Penelope’s cross-functional team leadership fosters collaboration across diverse disciplines, allowing her to leverage her deep knowledge in immunology, vaccines, and cardiology to address the unique challenges faced by clients. Her commitment to excellence and strategic vision positions PDC Pharma Strategy as a trusted partner in the pharmaceutical landscape, dedicated to advancing healthcare solutions while maintaining the highest standards of quality and compliance. With her profound understanding of 21 CFR Part 11 and computer system validation, Penelope continues to shape the future of pharmaceutical consulting, ensuring that PDC Pharma Strategy remains at the cutting edge of industry advancements.
